Personalized medicine and stroke prevention: where are we?

Vasc Health Risk Manag. 2015 Dec 2:11:601-11. doi: 10.2147/VHRM.S77571. eCollection 2015.

Abstract

There are many recommended pharmacological and non-pharmacological therapies for the prevention of stroke, and an ongoing challenge is to improve their uptake. Personalized medicine is seen as a possible solution to this challenge. Although the use of genetic information to guide health care could be considered as the apex of personalized medicine, genetics is not yet routinely used to guide prevention of stroke. Currently personalized aspects of prevention of stroke include tailoring interventions based on global risk, the utilization of individualized management plans within a model of organized care, and patient education. In this review we discuss the progress made in these aspects of prevention of stroke and present a case study to illustrate the issues faced by health care providers and patients with stroke that could be overcome with a personalized approach to the prevention of stroke.

Keywords: education; personalized health care; prevention; stroke.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Genetic Markers
  • Genetic Predisposition to Disease
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Patient Compliance
  • Patient Education as Topic
  • Phenotype
  • Precision Medicine*
  • Primary Prevention / methods*
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior
  • Secondary Prevention / methods*
  • Stroke / diagnosis
  • Stroke / genetics*
  • Stroke / therapy*

Substances

  • Genetic Markers